ICU Medical (NASDAQ:ICUI) issued an update on its FY18 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $8.30-8.70 for the period, compared to the Thomson Reuters consensus estimate of $7.58.

Shares of ICU Medical traded up $9.35, hitting $295.55, during mid-day trading on Thursday, MarketBeat Ratings reports. The company’s stock had a trading volume of 207,131 shares, compared to its average volume of 142,746. ICU Medical has a 52 week low of $164.00 and a 52 week high of $313.20. The firm has a market cap of $6.04 billion, a PE ratio of 51.98 and a beta of 0.36.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Wednesday, May 9th. The medical instruments supplier reported $2.26 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.84 by $0.42. ICU Medical had a return on equity of 9.55% and a net margin of 1.25%. The firm had revenue of $372.00 million during the quarter, compared to analyst estimates of $346.28 million. During the same period last year, the company posted $1.68 EPS. The business’s quarterly revenue was up 50.2% on a year-over-year basis. equities analysts forecast that ICU Medical will post 6.66 earnings per share for the current year.

ICUI has been the subject of several research analyst reports. BidaskClub lowered ICU Medical from a strong-buy rating to a buy rating in a research report on Thursday, April 19th. Zacks Investment Research lowered ICU Medical from a strong-buy rating to a hold rating in a research report on Thursday, May 3rd. ValuEngine upgraded ICU Medical from a buy rating to a strong-buy rating in a research note on Saturday, June 2nd. Finally, TheStreet downgraded ICU Medical from an a rating to a c+ rating in a research note on Wednesday, May 9th. One research analyst has rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Buy and an average target price of $311.00.

In other news, VP Virginia Ruth Sanzone sold 500 shares of the firm’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $269.85, for a total value of $134,925.00. Following the completion of the sale, the vice president now directly owns 617 shares in the company, valued at approximately $166,497.45. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Joseph R. Saucedo sold 1,566 shares of the firm’s stock in a transaction dated Monday, May 14th. The shares were sold at an average price of $269.02, for a total value of $421,285.32. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 181,310 shares of company stock valued at $53,842,954. 12.50% of the stock is currently owned by company insiders.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: Investing in Growth Stocks

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.